CompletedNCT01981759
D-Cycloserine Added to CBT for Delusions
About this title
Read the official source — NCT01981759Medication studyAges 18–68United StatesSchizophrenia
Understand this study
Who was this study for?
Listed age limits: 18 years to 68 years.
- Listed locations
- Baltimore and 1 more locationSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateStarted: February 2014
- Recruitment status
- Completed
- Enrollment listed in the registry
- 58
- Sponsor
- NYU Langone Health
- Sponsor type
- Unknown or unclear
- Study type
- Behavioral
- Intervention type
- Behavioural, Drug, Other
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 68 Years
- Official registry ID
- NCT01981759
- Official title
Show the full official title
D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Baltimore · New York
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is NYU Langone Health.
Did this study involve medication?
Yes. The study involved medication, including D-Cycloserine.
Who was this study for?
Listed age limits: 18 years to 68 years.
